Trial · NCT01302834
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | IMRT + Cisplatin | 424 | |
| Overall Study | STARTED | IMRT + Cetuximab | 425 | |
| Overall Study | Eligible | IMRT + Cisplatin | 406 | |
| Overall Study | Eligible | IMRT + Cetuximab | 399 | |
| Overall Study | Started Treatment | IMRT + Cisplatin | 398 | |
| Overall Study | Started Treatment | IMRT + Cetuximab | 394 | |
| Overall Study | AE Assessed 1 Month Post-treatment (PT) | IMRT + Cisplatin | 369 | |
| Overall Study | AE Assessed 1 Month Post-treatment (PT) | IMRT + Cetuximab | 363 | |
| Overall Study | AE Assessed 3 Months PT | IMRT + Cisplatin | 359 | |
| Overall Study | AE Assessed 3 Months PT | IMRT + Cetuximab | 367 | |
| Overall Study | AE Assessed 6 Months PT | IMRT + Cisplatin | 361 | |
| Overall Study | AE Assessed 6 Months PT | IMRT + Cetuximab | 352 | |
| Overall Study | AE Assessment 1 Year PT | IMRT + Cisplatin | 360 | |
| Overall Study | AE Assessment 1 Year PT | IMRT + Cetuximab | 351 | |
| Overall Study | AE Assessed 2 Years PT | IMRT + Cisplatin | 311 | |
| Overall Study | AE Assessed 2 Years PT | IMRT + Cetuximab | 303 | |
| Overall Study | AE Assessed 5 Years PT | IMRT + Cisplatin | 92 | |
| Overall Study | AE Assessed 5 Years PT | IMRT + Cetuximab | 86 | |
| Overall Study | Dental Health Assessed 1 Year PT | IMRT + Cisplatin | 267 | |
| Overall Study | Dental Health Assessed 1 Year PT | IMRT + Cetuximab | 267 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01302834/flow